Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Other Working Capital Changes came in at $22.1 million in Q2 2026, up 72.66% YoY from $12.8 million in Q2 2025, and up 234.85% on a QoQ basis from $6.6 million in Q1 2026.
Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Other Working Capital Changes data on file, last reported at $22.1 million in Q2 2026.
- Quarterly Other Working Capital Changes rose 72.66% year-over-year to $22.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $120.3 million (down 6.74% YoY) and the FY2025 annual result came in at $114.8 million, down 18.0% from the prior year.
- Other Working Capital Changes climbed to $22.1 million in Q2 2026, from $6.6 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $44.8 million in Q4 2024 to a low of -$19.3 million in Q3 2025.
- A 5-year average of $2.0 million and a median of -$3.9 million in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 14540.0% — and 2025, when it plunged 60.61%.
- Tracing FTRE's Other Working Capital Changes over 5 years: stood at $8.2 million in 2022, then plunged by 53.66% to $3.8 million in 2023, then jumped by 784.21% to $33.6 million in 2024, then soared by 79.17% to $60.2 million in 2025, then sank by 63.29% to $22.1 million in 2026.
- The last three Other Working Capital Changes figures came in at $22.1 million (Q2 2026), $6.6 million (Q1 2026), and $60.2 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.10 Mn |
| Jun 30, 2026 | -6.10 Mn |
| Jun 30, 2026 | -6.10 Mn |
| Mar 31, 2026 | -11.40 Mn |
| Mar 31, 2026 | -11.40 Mn |
| Mar 31, 2026 | -11.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Dec 31, 2025 | 11.40 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Sep 30, 2025 | -19.30 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Mar 31, 2025 | -17.60 Mn |
| Mar 31, 2025 | -17.60 Mn |
| Mar 31, 2025 | -17.60 Mn |
| Dec 31, 2024 | 44.80 Mn |
| Dec 31, 2024 | 44.80 Mn |